Decision Expands Access to the Sonata® Treatment for Women Suffering from Uterine Fibroids, offering a Minimally Invasive Alternative to Hysterectomy or Myomectomy Redwood City, CA – December 17, 2024 – Gynesonics Inc., a medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that New York […]
Cutting-edge incision-free solution advances standard of care for women with uterine fibroids REDWOOD CITY, CA, August 20, 2024 – Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is proud to announce that its Sonata® System has been used to treat over 10,000 women […]
REDWOOD CITY, CA, March 19, 2024 – Gynesonics®, Inc., a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce several executive appointments for the positions of Chief Marketing and Strategy Officer, Chief Human Resource Officer, and Vice President of Market Access and […]
REDWOOD CITY, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) — Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that with the support of the American College of Obstetrics and Gynecology (ACOG), the American Medical Association (AMA) has established a new Current […]
REDWOOD CITY, Calif., Oct. 17, 2023 (GLOBE NEWSWIRE) — Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that its Sonata® Procedure has been used to treat over 1,000 women in the United States and approximately 6,500 women globally since launch. With […]
REDWOOD CITY, CA, August 1, 2023 – Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that its Sonata® Procedure is now covered by UnitedHealthcare, effective August 1, 2023. UnitedHealthcare offers the full spectrum of health benefit programs for individuals, employers, and Medicare […]
REDWOOD CITY, Calif., April 11, 2023 (GLOBE NEWSWIRE) — Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced that Skip Baldino was appointed in early March to the role of President and Chief Executive Officer of the company. Mr. Baldino, who will also serve as […]
Dr. John Thoppil, Current President of the Texas Association of Obstetricians and Gynecologists (TAOG), Performs Sonata Procedure in Austin Redwood City, CA, October 5, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Dr. John Thoppil is the first physician in the […]
Redwood City, CA, September 29, 2021 – Gynesonics®, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that Robert Brown has joined the company as Chief Financial Officer, starting immediately. Mr. Brown’s background includes significant experience successfully scaling business in healthcare, including medical devices. He most […]